Product Details for ANDA 216282
DEXAMETHASONE (DEXAMETHASONE)
0.5MG
Marketing Status: Prescription
0.75MG
Marketing Status: Prescription
1.5MG
Marketing Status: Prescription
4MG
Marketing Status: Prescription
6MG
Marketing Status: Prescription
0.5MG
Marketing Status: Prescription
Active Ingredient: DEXAMETHASONE
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 001
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
DEXAMETHASONE (DEXAMETHASONE)
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 001
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
0.75MG
Marketing Status: Prescription
Active Ingredient: DEXAMETHASONE
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.75MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 002
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
DEXAMETHASONE (DEXAMETHASONE)
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.75MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 002
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
1.5MG
Marketing Status: Prescription
Active Ingredient: DEXAMETHASONE
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 003
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
DEXAMETHASONE (DEXAMETHASONE)
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 003
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
4MG
Marketing Status: Prescription
Active Ingredient: DEXAMETHASONE
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 004
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
DEXAMETHASONE (DEXAMETHASONE)
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 004
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
6MG
Marketing Status: Prescription
Active Ingredient: DEXAMETHASONE
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 6MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 005
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: DEXAMETHASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 6MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A216282
Product Number: 005
Approval Date: Feb 7, 2024
Applicant Holder Full Name: ZYDUS LIFESCIENCES LTD
Marketing Status: Prescription
Patent and Exclusivity Information